Preview

Antibiot Khimioter = Antibiotics and Chemotherapy

Advanced search

Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases

https://doi.org/10.24411/0235-2990-2019-100045

Abstract

The article describes different generations of antisense oligonucleotids (unmodified oligonucleotids, phosphorothioate oligomers, 2’-0-methyl and 2’-0-methoxy-ethyl modification of oligomers, phosphordiamidate morpholine oligomers and small interfering RNAs), the possible mechanism of their action, their use for prevention and treatment of hazardous and extremely hazardous viral infectious diseases. Phosphordiamidate morpholine oligomers and small interfering RNAs are most widely used in the development of emergency prevention and treatment of hazardous and extremely hazardous viral infectious diseases. The authors conclude, that further improvement of medications based on antisense oligonucleotids may be achieved by improving the structure of the latter and carrying out the search for new chemical modifications.

About the Authors

A. A. Petrov
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation


V. N. Lebedev
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation


T. E. Sizikova
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation


T. M. Plekhanova
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation


S. V. Borisevich
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation


Review

For citations:


Petrov A.A., Lebedev V.N., Sizikova T.E., Plekhanova T.M., Borisevich S.V. Analysis of Use of Antisense Oligonucleotides for Prevention and Treatment of Hazardous and Extremely Hazardous Viral Infectious Diseases. Antibiot Khimioter = Antibiotics and Chemotherapy. 2019;64(7-8):56-62. (In Russ.) https://doi.org/10.24411/0235-2990-2019-100045

Views: 497


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)